 Krystal Biotech Inc NASDAQ:KRYS has earned an average recommendation of Buy from the ten brokerages that are currently covering the stock, MarketBeat.com reports. Two investment analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. The average 12 month price objective among brokerages that have issued ... 